Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9

Blood

Volumn 98, Issue 12, 2001, Pages 3435-3440

  Yang, Yi ^a,b,c   Kuang, Yanan ^a,b,c   De Oca, Rocio Montes ^a,b,c   Hays, Tobias ^a,b,c   Moreau, Lisa ^a,b,c   Lu, Naifang ^a,b,c   Seed, Brian ^a,b,c   D'Andrea, Alan D ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ANIMAL CELL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FANCA GENE; FANCC GENE; FANCD2 GENE; FANCE GENE; FANCF GENE; FANCG GENE; FANCONI ANEMIA; FIBROBLAST; GENE; GENE DISRUPTION; GENETIC CODE; GONAD; HISTOPATHOLOGY; HOMOZYGOSITY; IONIZING RADIATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; STEM CELL; XRCC9 GENE;

EID: 0035760285     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.12.3435     Document Type: Article

References (41)

1. D'Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood. 1997;90:1725-1736.
2. Auerbach AD, Buchwald M, Joenje H. Fanconi anemia. In: Vogelstein B, Kinzler, KW, eds. Genetics of human cancer. New York, NY: McGraw Hill; 1997.
3. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110.
4. Duckworth-Rysiecki G, Taylor AMR. Effects on ionizing radiation on cells from Fanconi's anemia patients. Cancer Res. 1985;45:416-420.
5. Carreau M, Alon N, Bosnoyan-Collins L, Joenje H, Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mut Res. 1999;435:103-109.
6. Joenje H, Lo ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood. 1995;86:2156-2160.
7. Joenje H, Levitus M, Walsfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759-762.
8. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nat Genet. 1996;14:320-323.
9. The Fanconi Anemia Breast Cancer Consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet. 1996;14:324-328.
10. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992;356:763-767.
11. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
12. de Winter JP, Leveille F, van Berkel CGM, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306-1308.
13. de Winter JP, Rooimans MA, van der Weel L, et al. The Fanconi anemia complementation gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
14. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene is identical with human XRCC9. Nat Genet. 1998;20:281-283.
15. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249-262.
16. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet. 1997;17:487-490.
17. Garcia-Higuera I, Kuang Y, Naf D, Wasik J, D'Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol. 1999;19:4866-4873.
18. Waisfisz Q, de Winter JP, Kruyt F, et al. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci U S A. 1999;96:10320-10325.
19. Yamashita T, Kupfer GM, Naf D, et al. The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci U S A. 1998;95:13085-13090.
20. de Winter JP, van Der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000;9:2665-2674.
21. Medhurst AL, Huber PAJ, Waisfisz Q, de Winter JP, Mathew CG. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet. 2001;10:423-429.
22. Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet. 1996;12:448-451.
23. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 1996;88:49-58.
24. Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstitution ability. Exp Hematol. 1999;27:1667-1674.
25. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999;94:1-8.
26. Haneline LS, Broxmeyer HE, Cooper S, et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood. 1998;91:4092-4098.
27. Rathbun R, Faulkner G, Ostroski M, et al. Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood. 1997;90:974-985.
28. Gush KA, Fu K-L, Grompe M, Walsh CE. Pheno typic correction of Fanconi anemia group C knockout mice. Blood. 2000;95:700-704.
29. Battaile KP, Bateman RL, Mortimer D, Rathbun RK, Bagby G, Grompe M. In vivo selection of wild-type hematopoietic cells in a murine model of Fanconi anemia. Blood. 1999;94:2151-2158.
30. Noll M, Bateman RL, D'Andrea AD, Grompe M. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C. Mol Ther. 2001;3:14-23.
31. Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood. 2000;96:4064-4070.
32. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo: a laboratory manual. 2nd ed. New York, NY: CSHL Press; 1994:253-289.
33. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54:431-440.
34. Liu N, Lamerdin JE, Tucker JD, et al. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc Natl Acad Sci U S A. 1997;94:9232-9237.
35. Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86:159-171.
36. Elson A, Wang Y, Daugherty CJ, et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A. 1996;93:13084-13989.
37. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Gene Dev. 1996;10:2411-2422.
38. Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet. 1996;12:448-451.
39. D'Andrea AD. Fanconi anaemia forges a novel pathway. Nat Genet. 1996;14:240-242.
40. Hoatlin ME, Zhi Y, Ball H, et al. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood. 1999;94:3737-3747.
41. Cheng NC, van de Vrugt HJ, van der Valk MA, et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet. 2000;9:1805-1811.